| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.21 | 1e-05 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-05 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-05 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.59 | 0.0002 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0008 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0008 |